title: Treatment of toxic epidermal necrolysis syndrome with "disease-modifying" drugs: the controversy goes on.
authors.affiliation: Dermatology Unit, Kaplan Medical Center, Rechovot, Israel. wolf_r@netvision.net.il
authors.forename: Ronni
authors.initials: R
authors.lastname: Wolf
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Ruocco
authors.forename: Stefania
authors.initials: S
authors.lastname: Jablonska
mesh_terms: D002053:Burn Units; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use; D013262:Stevens-Johnson Syndrome / Q000628:therapy*
chemical_list: D007155:Immunologic Factors; D013256:Steroids